tenk.fyi

SANGAMO THERAPEUTICS, INC

SGMONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$57.8M

67.2% YoY

Net Income

-$97.9M

62.0% YoY

EPS

$-0.49

66.9% YoY

Cash

$41.9M

7.3% YoY

FY 2024 · As of 2024-12-31